● Started operations production for third parties.
● Market launch of our first branded product: Dolofen.
● Our participation in the Rx market begins.
● License Agreement with American Cyanamid
● First Joint Venture signed with Upjohn International Company.
● Acquisition of the Sofgel Facility in Venezuela
● Creation of DISMEC, our on-site engineering division.
● Joint Ventures and commercial agreements signed in Peru, Venezuela, Bolivia, Guatemala, Dominican Republic, and Chile.
● Construction of our Softgel Facility in Brazil
● ISO 9002:94
● Construction of the new Softgel Facility in Barranquilla
● ISO 9001:2000 certification in our new facilities
● Acquisition of Pharmayect - Sterile facility
● Commercial Agreements with US & Canadian Generic companies for ANDA submissions
● Commercial agreements signed in El Salvador and Panama
● Launch of the first product using our patented technology G-Tab ™ FDA Audit (2009): first Soft Gelatin Capsule Facility FDA approved in South America.
● S.E. Asia market entry
● ISO 14000 certification
● FDA approval of our Softgels and Hormones Facilities in Barranquilla